Identification Generic Name (2R)-2-(4-chlorophenyl)-2-[4-(1H-pyrazol-4-yl)phenyl]ethanamine DrugBank Accession Number DB07857 Background Not Available Type Small Molecule Groups Experimental Structure 
 
 
 3D Download  MOL SDF 3D-SDF PDB SMILES InChI 
 
 
  Similar Structures Structure for (2R)-2-(4-chlorophenyl)-2-[4-(1H-pyrazol-4-yl)phenyl]ethanamine (DB07857) ×  Close Weight Average: 297.782  Monoisotopic: 297.103275234  Chemical Formula C 17 H 16 ClN 3 Synonyms Not Available Pharmacology Indication Not Available Reduce drug development failure rates Build, train, & validate machine-learning models with evidence-based and structured datasets. See how     Build, train, & validate predictive machine-learning models with structured datasets. See how Contraindications & Blackbox Warnings Avoid life-threatening adverse drug events Improve clinical decision support with information on  contraindications & blackbox warnings, population restrictions, harmful risks, & more. Learn more     Avoid life-threatening adverse drug events & improve clinical decision support. Learn more Pharmacodynamics Not Available Mechanism of action Target Actions Organism U cAMP-dependent protein kinase catalytic subunit alpha Not Available Humans U cAMP-dependent protein kinase inhibitor alpha Not Available Humans Absorption Not Available Volume of distribution Not Available Protein binding Not Available Metabolism Not Available Route of elimination Not Available Half-life Not Available Clearance Not Available Adverse Effects Improve decision support & research outcomes With structured adverse effects data, including:  blackbox warnings, adverse reactions, warning & precautions, & incidence rates. Learn more     Improve decision support & research outcomes with our structured adverse effects data. Learn more Toxicity Not Available Pathways Not Available Pharmacogenomic Effects/ADRs  
 
 
 Not Available Interactions Drug Interactions  
 
 
 This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.  Not Available Food Interactions Not Available Categories Drug Categories Not Available Chemical Taxonomy Provided by  Classyfire Description This compound belongs to the class of organic compounds known as diphenylmethanes. These are compounds containing a diphenylmethane moiety, which consists of a methane wherein two hydrogen atoms are replaced by two phenyl groups. Kingdom Organic compounds Super Class Benzenoids Class Benzene and substituted derivatives Sub Class Diphenylmethanes Direct Parent Diphenylmethanes Alternative Parents Phenylpyrazoles  /  Monocyclic monoterpenoids  /  Aromatic monoterpenoids  /  Chlorobenzenes  /  Aralkylamines  /  Aryl chlorides  /  Heteroaromatic compounds  /  Azacyclic compounds  /  Organopnictogen compounds  /  Organochlorides  /  Monoalkylamines  /  Hydrocarbon derivatives 
 
 
  show 2 more Substituents Amine  /  Aralkylamine  /  Aromatic heteromonocyclic compound  /  Aromatic monoterpenoid  /  Aryl chloride  /  Aryl halide  /  Azacycle  /  Azole  /  Chlorobenzene  /  Diphenylmethane  /  Halobenzene  /  Heteroaromatic compound  /  Hydrocarbon derivative  /  Monocyclic monoterpenoid  /  Monoterpenoid  /  Organic nitrogen compound  /  Organochloride  /  Organohalogen compound  /  Organoheterocyclic compound  /  Organonitrogen compound  /  Organopnictogen compound  /  P-cymene  /  Phenylpyrazole  /  Primary aliphatic amine  /  Primary amine  /  Pyrazole 
 
 
  show 16 more Molecular Framework Aromatic heteromonocyclic compounds External Descriptors Not Available Affected organisms Not Available Chemical Identifiers UNII Not Available CAS number Not Available InChI Key HWVGILTYGZFGLR-QGZVFWFLSA-N InChI InChI=1S/C17H16ClN3/c18-16-7-5-14(6-8-16)17(9-19)13-3-1-12(2-4-13)15-10-20-21-11-15/h1-8,10-11,17H,9,19H2,(H,20,21)/t17-/m1/s1 IUPAC Name (2R)-2-(4-chlorophenyl)-2-[4-(1H-pyrazol-4-yl)phenyl]ethan-1-amine SMILES NC[C@@H](C1=CC=C(Cl)C=C1)C1=CC=C(C=C1)C1=CNN=C1 References General References Not Available External Links PubChem Compound 15602983 PubChem Substance 99444328 ChemSpider 13078464 BindingDB 16220 ChEMBL CHEMBL227924 ZINC ZINC000014960996 PDBe Ligand GVN PDB Entries 2uw5 Clinical Trials Clinical Trials  
 
 
 Phase Status Purpose Conditions Count Pharmacoeconomics Manufacturers Not Available Packagers Not Available Dosage Forms Not Available Prices Not Available Patents Not Available Properties State Solid Experimental Properties Not Available Predicted Properties Property Value Source Water Solubility 0.00314 mg/mL ALOGPS logP 3.74 ALOGPS logP 3.44 Chemaxon logS -5 ALOGPS pKa (Strongest Acidic) 14.63 Chemaxon pKa (Strongest Basic) 9.68 Chemaxon Physiological Charge 1 Chemaxon Hydrogen Acceptor Count 2 Chemaxon Hydrogen Donor Count 2 Chemaxon Polar Surface Area 54.7 Å 2 Chemaxon Rotatable Bond Count 4 Chemaxon Refractivity 87.48 m 3 ·mol -1 Chemaxon Polarizability 32.23 Å 3 Chemaxon Number of Rings 3 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon Predicted ADMET Features Property Value Probability Human Intestinal Absorption + 1.0 Blood Brain Barrier + 0.972 Caco-2 permeable + 0.5359 P-glycoprotein substrate Non-substrate 0.7962 P-glycoprotein inhibitor I Non-inhibitor 0.9531 P-glycoprotein inhibitor II Non-inhibitor 0.8089 Renal organic cation transporter Non-inhibitor 0.5549 CYP450 2C9 substrate Non-substrate 0.9095 CYP450 2D6 substrate Non-substrate 0.8409 CYP450 3A4 substrate Non-substrate 0.6872 CYP450 1A2 substrate Inhibitor 0.8189 CYP450 2C9 inhibitor Non-inhibitor 0.6239 CYP450 2D6 inhibitor Non-inhibitor 0.825 CYP450 2C19 inhibitor Inhibitor 0.656 CYP450 3A4 inhibitor Inhibitor 0.5883 CYP450 inhibitory promiscuity High CYP Inhibitory Promiscuity 0.9122 Ames test Non AMES toxic 0.5618 Carcinogenicity Non-carcinogens 0.5252 Biodegradation Not ready biodegradable 1.0 Rat acute toxicity 2.5272 LD50, mol/kg  Not applicable hERG inhibition (predictor I) Weak inhibitor 0.9176 hERG inhibition (predictor II) Non-inhibitor 0.6058    ADMET data is predicted using  admetSAR , a free tool for evaluating chemical ADMET properties. ( 23092397 )  Spectra Mass Spec (NIST) Not Available Spectra Spectrum Spectrum Type Splash Key Predicted GC-MS Spectrum - GC-MS Predicted GC-MS Not Available Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS Not Available Targets Build, predict & validate machine-learning models Use our structured and evidence-based datasets to  unlock newinsights and accelerate drug research. Learn more     Use our structured and evidence-based datasets to unlock new insights and accelerate drug research. Learn more 
 
 
  Details 1.  cAMP-dependent protein kinase catalytic subunit alpha Kind Protein Organism Humans Pharmacological action Unknown General Function Ubiquitin protein ligase binding Specific Function Phosphorylates a large number of substrates in the cytoplasm and the nucleus. Regulates the abundance of compartmentalized pools of its regulatory subunits through phosphorylation of PJA2 which bin... Gene Name PRKACA Uniprot ID P17612 Uniprot Name cAMP-dependent protein kinase catalytic subunit alpha Molecular Weight 40589.38 Da References Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [ Article ]  
 
 
  Details 2.  cAMP-dependent protein kinase inhibitor alpha Kind Protein Organism Humans Pharmacological action Unknown General Function Protein kinase a catalytic subunit binding Specific Function Extremely potent competitive inhibitor of cAMP-dependent protein kinase activity, this protein interacts with the catalytic subunit of the enzyme after the cAMP-induced dissociation of its regulato... Gene Name PKIA Uniprot ID P61925 Uniprot Name cAMP-dependent protein kinase inhibitor alpha Molecular Weight 7988.435 Da References Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [ Article ]  × Identify potential medication risks Easily compare up to 40 drugs with our drug interaction checker. Get severity rating, description, and management advice.  Learn more      Drug created at September 15, 2010 21:26 / Updated at June 12, 2020 16:52 